RxDoctor Payments Data

Roel Sepulveda

Psychiatric/Mental Health · Desoto, TXNPI 1326518085

Payments from drug & device makers

$1,068in general payments, 2019–2025

Across 64 payments — averaging $16.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$230
  • AbbVie$212
  • Takeda Pharmaceuticals U.S.A., Inc.$144
  • Otsuka America Pharmaceutical, Inc.$117
  • Neurocrine Biosciences, Inc.$85
  • Sunovion Pharmaceuticals Inc.$71
  • plus $209 from 7 others

What the payments were for

  • Food & beverage$1,068100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,068 in reported general payments places this provider in the 60th percentile of 2,724 psychiatric/mental health providers in Texas.

See all psychiatric/mental health providers in Texas

Medicare billing

Part B allowed, 2024
$4,851
Medicare patients
13
Services billed
56

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
VraylarCariprazine Hcl27$40,654
TrintellixVortioxetine Hydrobromide29$15,715
Lurasidone Hcl41$7,693
Aripiprazole111$6,204
Hydroxyzine Hcl179$5,207
Bupropion XlBupropion Hcl267$3,643
Buspirone Hcl214$3,109
Duloxetine Hcl217$2,622
Prazosin Hcl144$2,068
Trazodone Hcl201$1,804
Quetiapine Fumarate121$1,797
Atomoxetine Hcl14$1,117
Mirtazapine64$1,078
Gabapentin79$1,061
Doxepin Hcl66$1,015

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieVraylar$212$40,65427 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$144$15,71529 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 2,724 psychiatric/mental health providers in Texas.

Other psychiatric/mental health in Desoto

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →